Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06112938 · ClinicalTrials.gov registry record
Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia
A clinical trial of Stenotrophomonas Maltophilia Infection, sponsored by Methodist Health System.
- Completed
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT06112938 is a study of Stenotrophomonas Maltophilia Infection that has completed, run by Methodist Health System. The registered enrollment target is 110 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06112938, a study of Stenotrophomonas Maltophilia Infection, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Multi center, retrospective chart review of patients admitted to MHS hospitals from April 1, 2017 to March 31, 2022. Patients will be identified through the electronic medical record, and data from those that meet the study inclusion and exclusion criteria will be analyzed. Minimum inhibitory concentration (MIC) data will be interpreted per Clinical \& Laboratory Standards Institute (CLSI) standards to determine local patterns of resistance. Multivariable logistic regression will be performed to determine predictors of mortality for S. maltophilia isolates.
Conditions Studied
Interventions
- DRUG Antibiotic
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2025-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06112938
The ClinicalTrials.gov registry entry for NCT06112938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stenotrophomonas Maltophilia Infection appearing as the primary indexed condition, and to 1 intervention - of which Antibiotic is the first listed.
NCT06112938 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06112938 about?
NCT06112938 is a clinical study titled "Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia". Multi center, retrospective chart review of patients admitted to MHS hospitals from April 1, 2017 to March 31, 2022. Patients will be identified through the electronic medical record, and data from those that meet the study inclusion and exclusion criteria will be analyzed. Minimum inhibitory concen...
What is the current status of trial NCT06112938?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2022-07-21. Estimated completion is 2025-07-14.
What conditions does trial NCT06112938 study?
This clinical trial studies the following conditions: Stenotrophomonas Maltophilia Infection.
What interventions are being tested in trial NCT06112938?
The interventions under investigation include: Antibiotic (DRUG).
Who is sponsoring clinical trial NCT06112938?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06112938 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.